Results 81 to 90 of about 2,434,011 (201)

Towards leaving no one behind in North Macedonia: a mixed methods assessment of barriers to effective coverage with health services

International Journal for Equity in Health
Background The Government of North Macedonia’s Primary Health Care reform is committed to leaving no one behind on the path to Universal health Coverage (UHC).
Theadora Swift Koller, Jelena Kjetkovikj Janeva, Elena Ognenovska, Ana Vasilevska, Simona Atanasova, Chris Brown, Antoni Dedeu, Anne Johansen   +7 more
doaj   +1 more source

TIM-3 in Cardiovascular Disease. [PDF]

Curr Heart Fail Rep
Yousif LI, Sijtema AG, Chevalier MJ, de Boer RA, Meijers WC.   +4 more
europepmc   +1 more source

TIM-3 in AML: pathogenic roles and therapeutic targetability. [PDF]

Clin Exp Med
Zhong L, Soleimani Samarkhazan H.
europepmc   +1 more source

Tim Behrens [PDF]

Neuron, 2021
openaire   +1 more source

Phase-field modeling of border cell cluster migration in Drosophila. [PDF]

PLoS Comput Biol
Akhavan N, George A, Starz-Gaiano M, Peercy BE.   +3 more
europepmc   +1 more source

Radiation-induced MYB reduction unleashes TIM-3 expression in NK cells to attenuate antitumor immunity in colorectal cancer. [PDF]

J Transl Med
Tao G, Guo X, Xiong J, Yan S, Guo X, Hu K, Tai W, Bu LL, Qiu H, Wu Q.   +9 more
europepmc   +1 more source

EEOC v. Tim Dahle Imports, Inc. [PDF]

, 2009
Jenkins, Judge Bruce S.
core   +1 more source

CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β. [PDF]

J Exp Med
Jayaraman V, Prise IE, Kästele V, Tamburrano S, Wemyss K, Bridgeman HM, Daw RH, Strangward P, Sanderson A, Cruickshank SM, Konkel JE, Chew C, Yao C, Anderson CJ, Priller J, McColl B, Munro DAD, Martens L, Scott CL, Guilliams M, Adamson AD, Grainger JR, Shaw TN.   +22 more
europepmc   +1 more source

TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring Study. [PDF]

Pharmaceutics
O'Farrell C, Havenaar R, McAllister M, Hens B, Barker R, Mármol ÁL, Ansari A, Ooms T, Schilderink R, Schwabe R, Butler J, Stróžyk M, Martins Garcia T, Minekus D, Sarcevica I, Smith K, Tomaszewska I, Jones E, Batchelor H, Bellmann S.   +19 more
europepmc   +1 more source

Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity. [PDF]

Proc Natl Acad Sci U S A
Fu C, Ma T, Clausen BE, Mellman I, Jiang A.   +4 more
europepmc   +1 more source